[Pharmacological properties and clinical efficacies of tazobactam/piperacillin (Zosyn 2.25, Zosyn 4.5), an injectable antibiotic combined with beta-lactamase inhibitor].
Uji
Tatsuya
T
t-uji@taiho.co.jp
Hashimoto
Yoshikazu
Y
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D002648:Child; D002986:Clinical Trials as Topic; D024881:Drug Resistance, Bacterial; D006801:Humans; D007275:Injections, Intravenous; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D010878:Piperacillin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D000077725:Piperacillin, Tazobactam Drug Combination
D000900:Anti-Bacterial Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin